MAPK3 and breast carcinoma: MDA-MB-231 breast cancer cells evidenced high endogenous extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation [16]; thus, we investigated the effect of ECAL on ERK activity using AlphaScreen technology.